Simone Goebel1, H Maximilian Mehdorn. 1. Department of Neurosurgery, University Hospital Schleswig-Holstein, Schittenhelmstr 10, 24105, Kiel, Germany. goebels@nch.uni-kiel.de
Abstract
PURPOSE: The aim of this study was to provide the first prospective longitudinal assessment of anxiety and depression in patients with a benign intracranial meningioma (WHO° I). METHODS: The Hospital Anxiety and Depression Scale was applied prior to (t1) and directly after (t2) neurosurgery as well as 6 months after surgery (t3). The research was conducted in a single treatment centre in Germany. Numerous sociodemographic, medical, psychological and cognitive accompanying measures were assessed. The study population consisted of 52 meningioma patients. Additionally, a control group of 24 patients with malignant brain tumours (astrocytoma WHO° III) was assessed. RESULTS: In meningioma patients, anxiety was high prior to surgery but declined significantly after successful neurosurgical treatment. Low levels of depression were observed at all times. In contrast, astrocytoma patients showed constantly high levels of anxiety whilst depression increased over the course of the disease. Numerous medical, psychosocial and psychological factors were associated with psychiatric morbidity in meningioma patients. CONCLUSIONS: In conclusion, psychiatric morbidity of patients with benign intracranial meningiomas was comparable to that of the general population after successful neurosurgical treatment. Numerous associated factors suggest complex relationships within a biopsychosocial model. However, due to the small sample size and recruitment in a single institution, our results are of limited generalisability and need cross-validation in future studies.
PURPOSE: The aim of this study was to provide the first prospective longitudinal assessment of anxiety and depression in patients with a benign intracranial meningioma (WHO° I). METHODS: The Hospital Anxiety and Depression Scale was applied prior to (t1) and directly after (t2) neurosurgery as well as 6 months after surgery (t3). The research was conducted in a single treatment centre in Germany. Numerous sociodemographic, medical, psychological and cognitive accompanying measures were assessed. The study population consisted of 52 meningiomapatients. Additionally, a control group of 24 patients with malignant brain tumours (astrocytoma WHO° III) was assessed. RESULTS: In meningiomapatients, anxiety was high prior to surgery but declined significantly after successful neurosurgical treatment. Low levels of depression were observed at all times. In contrast, astrocytomapatients showed constantly high levels of anxiety whilst depression increased over the course of the disease. Numerous medical, psychosocial and psychological factors were associated with psychiatric morbidity in meningiomapatients. CONCLUSIONS: In conclusion, psychiatric morbidity of patients with benign intracranial meningiomas was comparable to that of the general population after successful neurosurgical treatment. Numerous associated factors suggest complex relationships within a biopsychosocial model. However, due to the small sample size and recruitment in a single institution, our results are of limited generalisability and need cross-validation in future studies.
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: David K Wellisch; Thomas A Kaleita; Donald Freeman; Timothy Cloughesy; Jeffrey Goldman Journal: Psychooncology Date: 2002 May-Jun Impact factor: 3.894
Authors: Staci D Arnold; Leslie M Forman; Bart D Brigidi; Karen E Carter; Holly A Schweitzer; Heather E Quinn; A Bebe Guill; James E Herndon; Renee H Raynor Journal: Neuro Oncol Date: 2008-02-26 Impact factor: 12.300
Authors: Cristina D'Angelo; Antonio Mirijello; Lorenzo Leggio; Anna Ferrulli; Vincenzo Carotenuto; Nadia Icolaro; Antonio Miceli; Vincenzo D'Angelo; Giovanni Gasbarrini; Giovanni Addolorato Journal: J Neurosurg Date: 2008-02 Impact factor: 5.115
Authors: Jens-Holger A Krannich; Peter Weyers; Stefan Lueger; Michael Herzog; Thomas Bohrer; Olaf Elert Journal: BMC Psychiatry Date: 2007-09-12 Impact factor: 3.630
Authors: Aiste Pranckeviciene; Sarunas Tamasauskas; Vytenis Pranas Deltuva; Robertas Bunevicius; Arimantas Tamasauskas; Adomas Bunevicius Journal: Support Care Cancer Date: 2016-02-11 Impact factor: 3.603
Authors: Lisanne C Verbruggen; Melissa M Hudson; Daniel C Bowers; Cécile M Ronckers; Gregory T Armstrong; Roderick Skinner; Eelco W Hoving; Geert O Janssens; Helena J H van der Pal; Leontine C M Kremer; Renée L Mulder Journal: J Neurooncol Date: 2020-02-22 Impact factor: 4.130
Authors: Edit Bosnyák; David O Kamson; Michael E Behen; Geoffrey R Barger; Sandeep Mittal; Csaba Juhász Journal: EJNMMI Res Date: 2015-10-17 Impact factor: 3.138
Authors: Fabian M Troschel; Christian Ramroth; Lars Lemcke; Jens Clasing; Amelie S Troschel; Martin Dugas; Walter Stummer; Rainer Wiewrodt; Ralf Brandt; Dorothee Wiewrodt Journal: J Clin Med Date: 2020-04-02 Impact factor: 4.241